664 related articles for article (PubMed ID: 9872626)
1. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Castro M
Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
Deresinski SC
Semin Respir Infect; 1997 Jun; 12(2):79-97. PubMed ID: 9195673
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
[TBL] [Abstract][Full Text] [Related]
4. [Therapy and prevention of pneumocystis carinii pneumonia].
Goebel FD; Bogner JR
Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
[No Abstract] [Full Text] [Related]
5. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.
Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C
N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
7. [Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A38-49. PubMed ID: 11577363
[TBL] [Abstract][Full Text] [Related]
8. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia.
Warren E; George S; You J; Kazanjian P
Pharmacotherapy; 1997; 17(5):900-16. PubMed ID: 9324180
[TBL] [Abstract][Full Text] [Related]
9. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
Masur H
Infect Agents Dis; 1992 Oct; 1(5):270-8. PubMed ID: 1344666
[TBL] [Abstract][Full Text] [Related]
11. [New aspects of epidemiology and treatment of Pneumocystis carinii infection].
Powierska-Czarny J; Gospodarek E; Czerwionka-Szaflarska M
Pol Merkur Lekarski; 2004 Nov; 17(101):534-7. PubMed ID: 15754652
[TBL] [Abstract][Full Text] [Related]
12. Optimizing PCP therapy.
Torres G; Cadman J
GMHC Treat Issues; 1997 Oct; 11(10):3-5. PubMed ID: 11364821
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis carinii pneumonia treatment in people infected with HIV.
Bellamy R
Clin Evid; 2004 Jun; (11):935-50. PubMed ID: 15652046
[No Abstract] [Full Text] [Related]
14. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Korraa H; Saadeh C
South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
Ioannidis JP; Cappelleri JC; Skolnik PR; Lau J; Sacks HS
Arch Intern Med; 1996 Jan; 156(2):177-88. PubMed ID: 8546551
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
[TBL] [Abstract][Full Text] [Related]
17. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.
Chan C; Montaner J; Lefebvre EA; Morey G; Dohn M; McIvor RA; Scott J; Marina R; Caldwell P
J Infect Dis; 1999 Aug; 180(2):369-76. PubMed ID: 10395851
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Bucher HC; Griffith L; Guyatt GH; Opravil M
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
[TBL] [Abstract][Full Text] [Related]
19. Atovaquone for Pneumocystis carinii pneumonia.
Med Lett Drugs Ther; 1993 Apr; 35(893):28-9. PubMed ID: 8450807
[No Abstract] [Full Text] [Related]
20. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
Gupta M; Stephenson K; Gauar S; Frenkel L
Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
